EGFR and neoplasm: A single daily dose of D-Prop significantly reduced tumor growth and improved the survival of NSG mice xenografted with G-415 p53 R282W gallbladder cancer (GBC) cells, accompanied with an increased EGFR internalization-arrest at recycling endosomes and reduced mutp53 protein levels.